• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野生型结节性硬化症2(Tsc2)基因及其C末端区域对肿瘤发生的抑制作用。

Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.

作者信息

Jin F, Wienecke R, Xiao G H, Maize J C, DeClue J E, Yeung R S

机构信息

Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9154-9. doi: 10.1073/pnas.93.17.9154.

DOI:10.1073/pnas.93.17.9154
PMID:8799170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC38611/
Abstract

The Tsc2 gene, which is mutationally inactivated in the germ line of some families with tuberous sclerosis, encodes a large, membrane-associated GTPase activating protein (GAP) designated tuberin. Studies of the Eker rat model of hereditary cancer strongly support the role of Tsc2 as a tumor suppressor gene. In this study, the biological activity of tuberin was assessed by expressing the wild-type Tsc2 gene in tumor cell lines lacking functional tuberin and also in rat fibroblasts with normal levels of endogenous tuberin. The colony forming efficiency of Eker rat-derived renal carcinoma cells was significantly reduced following reintroduction of wild-type Tsc2. Tumor cells expressing the transfected Tsc2 gene became more anchorage-dependent and lost their ability to form tumors in severe combined immunodeficient mice. At the cellular level, restoration of tuberin expression caused morphological changes characterized by enlargement of the cells and increased contact inhibition. As with the full-length Tsc2 gene, a clone encoding only the C terminus of tuberin (amino acids 1049-1809, including the GAP domain) was capable of reducing both colony formation and in vivo tumorigenicity when transfected into the Eker rat tumor cells. In normal Rat1 fibroblasts, conditional overexpression of tuberin also suppressed colony formation and cell growth in vitro. These results provide direct experimental evidence for the tumor suppressor function of Tsc2 and suggest that the tuberin C terminus plays an important role in this activity.

摘要

在一些结节性硬化症家族的生殖系中发生突变失活的Tsc2基因,编码一种名为结节蛋白的大型膜相关GTP酶激活蛋白(GAP)。对遗传性癌症的艾克大鼠模型的研究有力地支持了Tsc2作为肿瘤抑制基因的作用。在本研究中,通过在缺乏功能性结节蛋白的肿瘤细胞系以及内源性结节蛋白水平正常的大鼠成纤维细胞中表达野生型Tsc2基因,评估了结节蛋白的生物学活性。重新引入野生型Tsc2后,艾克大鼠来源的肾癌细胞的集落形成效率显著降低。表达转染Tsc2基因的肿瘤细胞变得更依赖贴壁生长,并失去了在严重联合免疫缺陷小鼠中形成肿瘤的能力。在细胞水平上,结节蛋白表达的恢复导致形态学变化,其特征为细胞增大和接触抑制增加。与全长Tsc2基因一样,一个仅编码结节蛋白C末端(氨基酸1049 - 1809,包括GAP结构域)的克隆,当转染到艾克大鼠肿瘤细胞中时,能够降低集落形成和体内致瘤性。在正常的大鼠1成纤维细胞中,结节蛋白的条件性过表达也抑制了体外集落形成和细胞生长。这些结果为Tsc2的肿瘤抑制功能提供了直接的实验证据,并表明结节蛋白C末端在该活性中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/5cc74c258e83/pnas01521-0371-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/13f74d9b863e/pnas01521-0369-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/e5c0f617d278/pnas01521-0370-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/527e36a0b1f3/pnas01521-0370-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/5cc74c258e83/pnas01521-0371-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/13f74d9b863e/pnas01521-0369-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/e5c0f617d278/pnas01521-0370-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/527e36a0b1f3/pnas01521-0370-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daae/38611/5cc74c258e83/pnas01521-0371-a.jpg

相似文献

1
Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.野生型结节性硬化症2(Tsc2)基因及其C末端区域对肿瘤发生的抑制作用。
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9154-9. doi: 10.1073/pnas.93.17.9154.
2
Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.艾克大鼠模型的结节性硬化症(Tsc2)基因易感性产物中存在有效的转录激活结构域。
Cancer Res. 1996 Feb 1;56(3):429-33.
3
Identification of the coding sequences responsible for Tsc2-mediated tumor suppression using a transgenic rat system.利用转基因大鼠系统鉴定负责TSC2介导的肿瘤抑制的编码序列。
Hum Mol Genet. 2002 Nov 15;11(24):2997-3006. doi: 10.1093/hmg/11.24.2997.
4
The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis.结节性硬化症2基因产物结节蛋白,在调节内吞作用中作为一种Rab5 GTP酶激活蛋白(GAP)发挥作用。
J Biol Chem. 1997 Mar 7;272(10):6097-100. doi: 10.1074/jbc.272.10.6097.
5
The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.结节性硬化症中,TSC2基因产物结节蛋白的GAP相关结构域是错义突变的靶点。
Hum Mol Genet. 1997 Oct;6(11):1991-6. doi: 10.1093/hmg/6.11.1991.
6
Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.结节性硬化症2信使核糖核酸及其蛋白产物结节蛋白在正常人类大脑及结节性硬化症患者脑损伤中的定位
Brain Pathol. 1996 Oct;6(4):367-75. doi: 10.1111/j.1750-3639.1996.tb00866.x.
7
Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.艾克大鼠患肾癌的易感性由结节性硬化症2(TSC2)基因的种系突变决定。
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11413-6. doi: 10.1073/pnas.91.24.11413.
8
Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells.通过在埃克大鼠肾癌细胞中替换Tsc2基因来抑制肿瘤表型。
Biochem Biophys Res Commun. 1996 Feb 6;219(1):70-5. doi: 10.1006/bbrc.1996.0183.
9
Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis.结节蛋白磷酸化调节其与错构瘤蛋白的相互作用。这两种蛋白与结节性硬化症有关。
J Biol Chem. 2001 Jun 15;276(24):21017-21. doi: 10.1074/jbc.C100136200. Epub 2001 Apr 4.
10
Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.TSC1和TSC2中的病理性突变破坏了错构瘤蛋白和结节性硬化蛋白之间的相互作用。
Hum Mol Genet. 2001 Dec 1;10(25):2899-905. doi: 10.1093/hmg/10.25.2899.

引用本文的文献

1
The role of TSC2 in breast cancer: a literature review.结节性硬化症复合物2(TSC2)在乳腺癌中的作用:文献综述
Front Oncol. 2023 May 12;13:1188371. doi: 10.3389/fonc.2023.1188371. eCollection 2023.
2
Targeted therapy for mTORC1-driven tumours through HDAC inhibition by exploiting innate vulnerability of mTORC1 hyper-activation.通过靶向 mTORC1 驱动的肿瘤的治疗方法,通过利用 mTORC1 过度激活的固有脆弱性进行 HDAC 抑制。
Br J Cancer. 2020 Jun;122(12):1791-1802. doi: 10.1038/s41416-020-0839-1. Epub 2020 Apr 27.
3
Molecular genetic diagnostics of tuberous sclerosis complex in Bulgaria: six novel mutations in the and genes.

本文引用的文献

1
Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells.通过在埃克大鼠肾癌细胞中替换Tsc2基因来抑制肿瘤表型。
Biochem Biophys Res Commun. 1996 Feb 6;219(1):70-5. doi: 10.1006/bbrc.1996.0183.
2
Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein.Rap1B小GTP结合蛋白对脑B-Raf蛋白激酶的激活作用。
J Biol Chem. 1996 Jan 19;271(3):1258-61. doi: 10.1074/jbc.271.3.1258.
3
Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.
保加利亚结节性硬化症复合体的分子遗传学诊断:TSC1和TSC2基因中的六个新突变
J Genet. 2018 Jun;97(2):419-427.
4
VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformation.VPS34调节TSC1/TSC2异二聚体,以介导RheB和mTORC1/S6K1的激活及细胞转化。
Oncotarget. 2016 Aug 9;7(32):52239-52254. doi: 10.18632/oncotarget.10469.
5
Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway Activation.由TSC2单倍体不足驱动的间充质肿瘤发生需要HMGA2且独立于mTOR信号通路激活。
Cancer Res. 2016 Feb 15;76(4):844-54. doi: 10.1158/0008-5472.CAN-15-1287. Epub 2016 Feb 2.
6
Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.小鼠中神经嵴特异性TSC1缺失导致硬化性颅面骨病变。
J Bone Miner Res. 2015 Jul;30(7):1195-205. doi: 10.1002/jbmr.2447.
7
A novel androgen-regulated isoform of the TSC2 tumour suppressor gene increases cell proliferation.一种新的雄激素调节的TSC2肿瘤抑制基因同工型可促进细胞增殖。
Oncotarget. 2014 Jan 15;5(1):131-9. doi: 10.18632/oncotarget.1405.
8
TSC1 controls distribution of actin fibers through its effect on function of Rho family of small GTPases and regulates cell migration and polarity.TSC1 通过其对 Rho 家族小 GTPases 功能的影响控制肌动蛋白纤维的分布,调节细胞迁移和极性。
PLoS One. 2013;8(1):e54503. doi: 10.1371/journal.pone.0054503. Epub 2013 Jan 23.
9
Glucose deprivation in tuberous sclerosis complex-related tumors.结节性硬化症相关肿瘤的葡萄糖剥夺。
Cell Biosci. 2011 Oct 21;1:34. doi: 10.1186/2045-3701-1-34.
10
Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition.结节性硬化症蛋白调节 E-钙黏蛋白的定位:在上皮-间充质转化中的作用。
Am J Pathol. 2010 Oct;177(4):1765-78. doi: 10.2353/ajpath.2010.090233. Epub 2010 Sep 2.
艾克大鼠模型的结节性硬化症(Tsc2)基因易感性产物中存在有效的转录激活结构域。
Cancer Res. 1996 Feb 1;56(3):429-33.
4
The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord.结节性硬化症2基因在小脑和发育中的脊髓中高水平表达。
Cell Growth Differ. 1995 Nov;6(11):1477-83.
5
Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues.结节性硬化症2信使核糖核酸剪接变体的鉴定,这些变体在大鼠和人类组织中保守且差异表达。
Cell Growth Differ. 1995 Sep;6(9):1185-91.
6
Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer.在显性遗传癌症的埃克大鼠模型中自发和辐射诱导的肾肿瘤。
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):327-31. doi: 10.1073/pnas.90.1.327.
7
The tumor suppressor genes.肿瘤抑制基因。
Annu Rev Biochem. 1993;62:623-51. doi: 10.1146/annurev.bi.62.070193.003203.
8
Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.神经纤维瘤蛋白可通过一种独立于其GTP酶加速功能的机制抑制Ras依赖性生长。
Mol Cell Biol. 1994 Jan;14(1):641-5. doi: 10.1128/mcb.14.1.641-645.1994.
9
Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.结节性硬化症患者错构瘤中16号染色体p13.3区域的杂合性缺失
Nat Genet. 1994 Feb;6(2):193-6. doi: 10.1038/ng0294-193.
10
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.通过可诱导系统表达细胞周期蛋白D1和E来加速G1/S期转换
Mol Cell Biol. 1994 Mar;14(3):1669-79. doi: 10.1128/mcb.14.3.1669-1679.1994.